» Articles » PMID: 11346799

Phagocytosis and Clearance of Apoptotic Cells is Mediated by MER

Overview
Journal Nature
Specialty Science
Date 2001 May 11
PMID 11346799
Citations 537
Authors
Affiliations
Soon will be listed here.
Abstract

Apoptosis is fundamental to the development and maintenance of animal tissues and the immune system. Rapid clearance of apoptotic cells by macrophages is important to inhibit inflammation and autoimmune responses against intracellular antigens. Here we report a new function for Mer, a member of the Axl/Mer/Tyro3 receptor tyrosine kinase family. mer(kd) mice with a cytoplasmic truncation of Mer had macrophages deficient in the clearance of apoptotic thymocytes. This was corrected in chimaeric mice reconstituted with bone marrow from wild-type animals. Primary macrophages isolated from mer(kd) mice showed that the phagocytic deficiency was restricted to apoptotic cells and was independent of Fc receptor-mediated phagocytosis or ingestion of other particles. The inability to clear apoptotic cells adequately may be linked to an increased number of nuclear autoantibodies in mer(kd) mice. Thus, the Mer receptor tyrosine kinase seems to be critical for the engulfment and efficient clearance of apoptotic cells. This has implications for inflammation and autoimmune diseases such as systemic lupus erythematosus.

Citing Articles

MERTK inhibition improves therapeutic efficacy of immune checkpoint inhibitors in hepatocellular carcinoma.

Llopiz D, Silva L, Ruiz M, Castro-Alejos C, Aparicio B, Vegas L Oncoimmunology. 2025; 14(1):2473165.

PMID: 40029206 PMC: 11881874. DOI: 10.1080/2162402X.2025.2473165.


Efferocytosis and inflammation: a bibliometric and systematic analysis.

Cao X, Li F, Xie X, Ling G, Tang X, He W Front Med (Lausanne). 2025; 12:1498503.

PMID: 39995691 PMC: 11847848. DOI: 10.3389/fmed.2025.1498503.


Early-age efferocytosis directs macrophage arachidonic acid metabolism for tissue regeneration.

Lantz C, Becker A, DeBerge M, Filipp M, Glinton K, Ananthakrishnan A Immunity. 2025; 58(2):344-361.e7.

PMID: 39938482 PMC: 11839170. DOI: 10.1016/j.immuni.2024.11.018.


AXL signaling in cancer: from molecular insights to targeted therapies.

Yadav M, Sharma A, Patne K, Tabasum S, Suryavanshi J, Rawat L Signal Transduct Target Ther. 2025; 10(1):37.

PMID: 39924521 PMC: 11808115. DOI: 10.1038/s41392-024-02121-7.


ICAM1 gingival fibroblasts modulate periodontal inflammation to mitigate bone loss.

Kim W, Prasongyuenyong K, Ko A, Debnath R, Chen Z, Zhou J Front Immunol. 2024; 15:1484483.

PMID: 39650645 PMC: 11621011. DOI: 10.3389/fimmu.2024.1484483.